(Q45879745)

17 December 2017

title

Nonmyeloablative conditioning generates autoantigen-encoding bone marrow that prevents and cures an experimental autoimmune disease (English)

1 reference

17 December 2017

author

Frank Alderuccio

5

1 reference

17 December 2017

author name string

Z Nasa

1

1 reference

17 December 2017

J-Y Chung

2

1 reference

17 December 2017

J Chan

3

1 reference

17 December 2017

B-H Toh

4

1 reference

17 December 2017

language of work or name

English

0 references

publication date

13 June 2012

1 reference

17 December 2017

American Journal of Transplantation

published in

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

2062-2071

1 reference

17 December 2017

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

1 reference

Autologous haematopoietic-stem-cell transplantation for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Treatment of severe autoimmune disease by stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Will hematopoietic stem cell transplantation cure human autoimmune diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Autologous haemopoietic stem cell transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Prevention of type 1 diabetes by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Non-myeloablative transplantation of bone marrow expressing self-antigen establishes peripheral tolerance and completely prevents autoimmunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Hematopoietic stem cell transplantation procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

20 years of gene therapy for SCID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04068.X

10.1111/J.1600-6143.2012.04068.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

22694476

1 reference

17 December 2017